| Dr Krista Donabella, PHARMD | |
|
1344 Gerling St, Schenectady, NY 12308-1702 | |
| (518) 930-7357 | |
| (518) 930-7358 |
| Full Name | Dr Krista Donabella |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1344 Gerling St, Schenectady, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114330933 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 057146 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Krista Donabella, PHARMD 1344 Gerling St, Schenectady, NY 12308-1702 Ph: (518) 930-7357 | Dr Krista Donabella, PHARMD 1344 Gerling St, Schenectady, NY 12308-1702 Ph: (518) 930-7357 |
News Archive
The study, published in the journal Science and Technology of Advanced Materials, by Shinichi Arakawa and colleagues at Tokyo Medical and Dental University and Japan's National Institute of Advanced Industrial Science and Technology, evaluated the bactericidal activities of ozone nano-bubble water - also known as NBW3 - against the two main bacterial agents that cause periodontitis as well as its toxicity to human oral tissue cells.
Retailers should be licensed to sell cigarettes, and the licence revoked if they are caught selling tobacco to children, the Australian Medical Association (WA) said today.
Over the past decade, humanitarian aid worker casualties have tripled, rising to more than 100 deaths per year, according to a report (.pdf) released Tuesday by the U.N. Office for the Coordination of Humanitarian Assistance (OCHA), the Associated Press reports (Snow, 4/12).
Isis Innovation, the University of Oxford's technology commercialisation company, and Ludwig Cancer Research are proud to announce the launch of a new spinout company, iOx Therapeutics. iOx Therapeutics will develop a novel cancer immunotherapy discovered through a collaboration between Ludwig Cancer Research and Professor Vincenzo Cerundolo, the director of the MRC Human Immunology Unit within the University of Oxford's Weatherall Institute of Molecular Medicine.
Generex Biotechnology Corporation, the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that it has now achieved 75% of the required number of per-protocol completers in its ongoing six month pivotal global Phase III study of Generex Oral-lyn™, the Company's proprietary buccal insulin spray product.
› Verified 2 days ago
Katelyn Ann Masullo, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1628 Chrisler Ave, Schenectady, NY 12303 Phone: 518-382-5391 | |
Justin George, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 461 Nott St, Schenectady, NY 12308 Phone: 518-379-2262 | |
Linda Rosen, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3333 Consaul Rd, Schenectady, NY 12304 Phone: 518-395-9798 | |
Jill A Mattice, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2617 Hamburg St, Schenectady, NY 12303 Phone: 518-355-4002 | |
Matthew Harrington, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3333 Consaul Rd Ste 6, Schenectady, NY 12304 Phone: 518-395-9798 | |
Dr. Nimish Patel, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1409 Altamont Ave, Eckerds Pharmacy, Schenectady, NY 12303 Phone: 518-355-2008 Fax: 518-477-7907 | |
Dr. Christopher James Mcnall, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1204 Eastern Ave, Schenectady, NY 12308 Phone: 518-372-0250 Fax: 518-372-2530 |